Moderna News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

30.01.23	Moderna Announces FDA's Breakthrough Designation For MRNA-1345; Plans License Application In H1 (RTTNews)
27.01.23	FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots (RTTNews)
18.01.23	Pre-market Movers: FUV, CYAD, ATXI, CSSE, PXMD… (RTTNews)
17.01.23	Moderna RSV Vaccine Meets Primary Endpoints In Phase 3 Trial (RTTNews)
09.01.23	Moderna Reiterates 2023 Expected Minimum COVID-19 Vaccines Sales (RTTNews)
04.01.23	Moderna To Buy Privately Held OriCiro Genomics For $85 Mln (RTTNews)
16.12.22	Moderna: CHMP Recommends Approval Of Bivalent COVID-19 Booster In Children (RTTNews)
13.12.22	Moderna, Merck's Phase 2b Trial Of MRNA-4157/V940 Combination In Melanoma Meets Primary Endpoint (RTTNews)
28.11.22	Form 4 1682852 (RSS)
18.11.22	Form 4 1682852 (RSS)
17.11.22	Form 4 1655210 (RSS)
14.11.22	Moderna Says Both Bivalent Omicron-targeting Booster Candidates Trigger Superior Antibody Response (RTTNews)
11.11.22	Harbour BioMed Collaborates With Moderna On Nucleic Acid-based Immunotherapies (RTTNews)
10.11.22	Form 10-Q 1655210 (RSS)
09.11.22	Form 8-K 1655210 (RSS)
08.11.22	Form 4 1682852 (RSS)
03.11.22	Moderna Stock Plunges 12% As Q3 Results Miss Estimates (RTTNews)
03.11.22	Form 8-K 1682852 (RSS)
28.10.22	Form 4 1682852 (RSS)
20.10.22	Initial statement of beneficial ownership of securities (RSS)
20.10.22	EMA Recommends Authorization Of Moderna's Omicron BA.4-BA.5 Targeting Bivalent COVID-19 Vaccine (RTTNews)
17.10.22	Moderna, Gavi Terminate Remaining COVID-19 Vaccine Orders Amid Sufficient Supply (RTTNews)
14.10.22	Statement of changes in beneficial ownership of securities (RSS)
14.10.22	Statement of changes in beneficial ownership of securities (RSS)
06.10.22	Statement of acquisition of beneficial ownership by individuals (RSS)
06.10.22	Statement of acquisition of beneficial ownership by individuals (RSS)
04.10.22	Initial statement of beneficial ownership of securities (RSS)
29.09.22	Moderna Expands Executive Committee In Preparation For Multiple Upcoming New Product Launches (RTTNews)
12.09.22	Moderna Says Japan Approved Partial Change To NDA For Its Omicron Booster (RTTNews)
08.09.22	DGAP-News: Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day (EQS Group)
01.09.22	Adapted Versions Of Pfizer's Comirnaty & Moderna's Spikevax Recommended For Approval In The EU (RTTNews)
01.09.22	FDA Authorizes Moderna, Pfizer-BioNTech Omicron Boosters (RTTNews)
29.08.22	Moderna's Omicron-targeting Booster Covid-19 Vaccine Gets Clearance In Switzerland (RTTNews)
29.08.22	DGAP-News: Moderna, Inc.: Swissmedic Authorizes Modernas Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214 (EQS Group)
26.08.22	Moderna Sues Pfizer, BioNTech For Patent Infringement (RTTNews)
26.08.22	Statement of changes in beneficial ownership of securities (RSS)
23.08.22	Statement of changes in beneficial ownership of securities (RSS)
22.08.22	Moderna: Canada Exercises Option To Purchase 4.5 Mln Doses Of Omicron-containing Bivalent Vaccine (RTTNews)
17.08.22	Moderna Names James Mock CFO; David Meline To Retire (RTTNews)
15.08.22	DGAP-News: Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK (EQS Group)
09.08.22	DGAP-News: Moderna And the European Commission (EC) Amend Covid-19 Vaccine Agreement to Supply Omicron-Containing Bivalent Candidates; EC Purchases Additional 15 million Doses (EQS Group)
03.08.22	Moderna Q2 Results Top Estimates (RTTNews)
22.07.22	DGAP-News: EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European Union (EQS Group)
08.07.22	Initial statement of beneficial ownership of securities (RSS)
29.06.22	FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall (RTTNews)
29.06.22	Initial statement of beneficial ownership of securities (RSS)
24.06.22	Statement of changes in beneficial ownership of securities (RSS)
22.06.22	Moderna Announces New Clinical Data On Omicron COVID Booster Candidate MRNA-1273.214 (RTTNews)
22.06.22	Moderna Plans To Establish MRNA Manufacturing And Research Center In U.K. (RTTNews)
16.06.22	FDA Advisers Recommend Pfizer, Moderna COVID-19 Vaccines For Kids As Young As 6 Months (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus
22.11.24		Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Gewinne in New York: NASDAQ 100 präsentiert sich fester
22.11.24		Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500
22.11.24		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus

22.11.24

Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Gewinne in New York: NASDAQ 100 präsentiert sich fester

22.11.24

Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500